Little is known about how the individual decision styles and values of breast cancer patients at the time of treatment decision making are associated with the consideration of different treatment options and specifically with the consideration of contralateral prophylactic mastectomy (CPM). METHODS: Newly diagnosed patients with early-stage breast cancer who were treated in 2013-2014 were identified through the Surveillance, Epidemiology, and End Results registries of Los Angeles and Georgia and were surveyed approximately 7 months after surgery (n 5 2578; response rate, 71%). The primary outcome was the consideration of CPM (strong vs less strong). The association between patients' values and decision styles and strong consideration was assessed with multivariate logistic regression. RESULTS: Approximately one-quarter of women (25%) reported strong/very strong consideration of CPM, and another 29% considered it moderately/weakly. Decision styles, including a rational-intuitive approach to decision making, varied. The factors most valued by women at the time of treatment decision making were as follows: avoiding worry about recurrence (82%) and reducing the need for more surgery (73%). In a multivariate analysis, patients who preferred to make their own decisions, those who valued avoiding worry about recurrence, and those who valued avoiding radiation significantly more often strongly considered CPM (P < .05), whereas those who reported being more logical and those who valued keeping their breast did so less often. CONCLU-SIONS: Many patients considered CPM, and the consideration was associated with both decision styles and values. The variability in decision styles and values observed in this study suggests that formally evaluating these characteristics at or before the initial treatment encounter could provide an opportunity for improving patient clinician discussions. Cancer 2017;123:4547-55.
INTRODUCTION
The surge in the use of contralateral prophylactic mastectomy (CPM) after the diagnosis of breast cancer has motivated interest in understanding how the treatment decision-making process can drive a patient's desire for aggressive procedures that increase morbidity in the absence of a survival benefit. The frequency of CPM has increased from a relatively low rate among women who do not have an elevated risk of developing a second primary breast cancer to a rate greater than 20% in this population, and CPM now represents approximately half of mastectomies performed for breast cancer in the United States. [1] [2] [3] Importantly, many more women consider undergoing the procedure in comparison with those actually undergoing it.
Remarkably little research has been done to examine the psychological factors that drive a patient's desire for CPM. Several studies that have examined correlates of the use of CPM have observed that the procedure is undergone primarily by more highly educated, white, and insured patients. [2] [3] [4] [5] [6] [7] Research exploring the patient perspective has found women's choices for the procedure to be driven by worry about recurrence and a desire for peace of mind as well as a desire for better cosmetic outcomes. 2, 5 However, this literature has been limited by a focus on the characteristics of those patients who ultimately undergo CPM. Indeed, very little is known about all patients who think seriously about undergoing CPM, including those who do not ultimately undergo the procedure. Surgeons must be able to identify this much broader group of women, whose concerns must be addressed as part of the treatment decisionmaking process.
To address this gap in the literature, our study had 2 objectives. First, we characterized patient perspectives about the importance of different factors related to treatments (values) and underlying attitudes toward decision making (decision styles) in a large, diverse, population-based sample of patients with early-stage breast cancer at average risk for the development of a second primary cancer. Second, we evaluated correlates of strong consideration of CPM, including patient decision styles and values.
MATERIALS AND METHODS

Study Population
The iCanCare study, a large, diverse, population-based survey study of women with favorable-prognosis breast cancer, accrued women aged 20 to 79 years with newly diagnosed breast cancer (ductal carcinoma in situ and stage I and II cancer, <5 cm in size) as identified by rapid reporting systems from the Surveillance, Epidemiology, and End Results (SEER) registries of Georgia and Los Angeles County in 2013-2014. Black, Asian, and Hispanic women were oversampled in Los Angeles. 8 We selected 3880 women, of whom 249 were later deemed ineligible because they had a prior cancer diagnosis or stage III or IV disease; resided outside the SEER registry area; or were deceased, too ill, or unable to complete a survey in Spanish or English. Of the 3631 eligible women remaining, 1053 did not return the mailed surveys, refused to participate, or were lost to follow-up. Among the 2578 respondents (71%), 216 were excluded because they had bilateral disease and/or were a genetic mutation carrier as reported on the survey. The resulting analytic sample was 2362 women (Supporting Fig. 1 [see online supporting information]).
Data Collection
Patients were sent surveys approximately 2 to 3 months after surgery, and the median completion time was 6 to 7 months after surgery. We provided a $20 cash incentive and used a modified Dillman method for patient recruitment. 9 All materials were sent in English and Spanish to those with Spanish surnames. 8 Survey responses were then merged with clinical data from SEER. This study was approved by the institutional review boards of the University of Michigan, the University of Southern California, and Emory University.
Questionnaire Design and Content
The patient questionnaire content was guided by a conceptual framework, research questions, and hypotheses. Drawing from the literature and our prior research, [10] [11] [12] we chose established measures when they were available and developed new measures when it was necessary. [10] [11] [12] We used standard techniques to assess content validity, including a review by survey design experts, cognitive pretesting with patients, and pilot studies in select clinic populations. Relevant measures from the iCanCare patient survey are provided in supporting information.
Primary Outcome: Consideration of CPM
We asked women to indicate on a 5-point Likert scale how much they considered having a mastectomy on their unaffected breast (from not at all to very strongly). We looked at any consideration (weak, moderate, strong, or very strong) versus not at all as well as categorization into 2 groups: strong/very strong versus other. For all but our initial descriptive analyses of this variable, we focused on the latter dichotomized comparison.
Key Independent Variables
Decision style factors
We used 3 measures designed to assess women's underlying approach to decision making (decision styles) on the basis of prior work.
Decision-making apprehension scale. This scale consisted of 4 items, each of which was scored with a 5-point Likert scale (ranging from not at all to almost always). The items were designed to assess how women normally approach the emotional side of decision making: 1) I worry about making a bad decision; 2) I struggle to decide what the right decision is; 3) once I make a decision, I don't look back; and 4) I worry a lot about the outcomes of my decisions. The Cronbach a value for the scale was .78, and it formed a single factor, with higher scores indicating more decision-making apprehension. usually more rational or more intuitive in their approach to general decision making on the basis of literature in decision psychology. 13 The items were scored with a 4-point Likert-like scale:
1. Did you rely on your instincts and feelings or weigh the pros and cons (scale, [1] instincts to [4] Each of these items was dichotomized.
Decision autonomy preference. We asked 2 questions to assess the desired role in decision making. Patients were asked to indicate the degree to which they wanted their physician to tell them what to do and the degree to which they preferred to make their own breast cancer treatment decisions. Each item was scored on a 5-point scale ranging from not at all to all the time, and each was categorized as quite a bit/all the time or less. 14 
Patient values
We assessed the women's reports of the importance of 16 underlying values related to breast cancer treatment. For each value, we asked women to indicate how important it was at the time of making the treatment decision on a 5-point Likert scale (ranging from not at all important to very important). For the analysis, an indicator was created for reporting the very or quite important category versus other categories.
Covariates
The covariates used in this analysis included patient demographics obtained from the patient questionnaire. We included age, race/ethnicity (white, black, Latina, Asian, or other/unknown), educational attainment (high school graduate or less or some college or more), marital status (married/partnered vs not married/partnered), income group (<$40,000, $40,000 to <$90,000, or $90,000), insurance status (private, Medicare, Medicaid, other, or none), bra cup size (A/B, C, D, or DD1), and a family history of breast cancer (none vs 1 or more first-degree relatives). We also included whether the patient reported having undergone magnetic resonance imaging (yes, no, or missing). The stage (0, I, or II) was collected from SEER. An indicator of high risk for having a genetic mutation was created from both the patient report and the SEER variables, as described elsewhere. 3 The geographic site (Georgia or Los Angeles) was also included to account for regional differences.
Statistical Analyses
We first calculated the proportion of women who considered CPM strongly or very strongly (hereafter referred to as strong consideration) overall and by all demographic and clinical factors, including the risk status. We generated descriptive statistics of each decision style measure and for all 16 values overall by generating the proportion indicating that each value was quite/very important. We then evaluated associations between these measures and strong consideration of CPM after adjustments for the covariates noted previously.
Multivariate logistic regression was used to explore correlates of strong consideration of CPM, including decision style factors, values, and covariates that remained significant at P < .05 in the adjusted analyses. Parsimonious multivariate models were constructed with backward selection techniques with a 3-step approach. First, decision style factors and values were modeled separately along with all demographic and clinical factors to determine important decision style factors and values. Second, significant decision style factors and values from each model were then modeled simultaneously, again with all demographic and clinical factors retained. Finally, significant decision style factors, values, and demographic and clinical factors were retained to arrive at the final parsimonious model. This model was adjusted for clustering at the surgeon level to account for potential surgeon-level practice attributes that could affect patients' consideration of CPM, such as the availability of or propensity to refer to reconstructive surgeons. [15] [16] [17] All statistical analyses incorporated weights to account for differential probabilities of sample selection and nonresponse. The survey and SEER item nonresponse rate was low (<5%) for all covariates. We compared the distributions of nonrespondents and respondents for age, race, stage, and site. White patients (vs minorities) and those with stage I cancer (vs those with stage II cancer) were significantly more likely to respond, and we then addressed this via weighting to ensure that the analyses were representative of the original population.
To correct for a potential bias due to missing data, values for missing items were imputed with sequential multiple imputation. 18, 19 Five multiply imputed data sets were analyzed, and model estimates were combined to account for additional uncertainty due to imputation. The results were compared between sequential multiple imputation analyses and complete case analyses for any meaningful differences. Odds ratios (ORs) with 95% confidence intervals (CIs) are reported for models, with P values .05 considered significant. All analyses were performed with SAS 9.4 (SAS, Cary, North Carolina).
RESULTS
Sample Characteristics
The characteristics of the sample overall and by the degree of consideration of CPM are provided in Table 1 . The Overall, approximately one-quarter (25%) of the women reported strong or very strong consideration of CPM, and another 29% considered it moderately or weakly. Of those who considered it strongly, 13% underwent unilateral mastectomy, and 16% underwent breast conservation. In bivariate analyses, women who considered CPM strongly/very strongly were younger, were more educated, were white, had private insurance, had a family history of breast cancer, and were more often from Georgia.
Decision Styles
The mean score on the decision apprehension scale was 2.5 (range, 1 [not very apprehensive] to 5 [very apprehensive]). More than half of the respondents reported that they were more rational than intuitive (75%), more often thought through decisions rather than going with their instinct (78%), more often reviewed details rather than making quick decisions (61%), and were more logical rather than following their heart (83%) in their approach to treatment decision making. More than half (59%) indicated that they wanted their physician to tell them what to do quite/all the time, and just more than one-third (37%) reported that they preferred to make their own decisions quite a bit/all the time.
Values
There was considerable variation in the factors valued by patients in making treatment decisions. Figure 1 shows the percentage of patients who indicated that each value or value group was "very or quite important" to them in making their treatment decision. The most common value that women reported being quite/very important was allowing them to avoid worry about the cancer coming back (82%); this was followed by reducing the need for more surgery (73%), being the newest, most advanced treatment (69%), and avoiding treatment side effects (67%). The value least commonly reported to be quite/ very important was receiving the same treatments that other women had received (23%). Table 2 shows the ORs for associations between individual decision styles and values and strong consideration of CPM after adjustments for the patient demographic and disease characteristics in separate regression models. Having a higher level of decision apprehension was modestly associated with strong consideration (OR, 1.14; 95% CI, 0.99-1.31), whereas women who reported more logical approaches to decision making were less likely to have strongly considered CPM (OR, 0.52; 95% CI, 0.31-0.71). Women who preferred their physician to make the decision less often strongly considered CPM (OR, 0.69; 95% CI, 0.55-0.87), whereas women who preferred to make their own treatment decisions more often strongly considered CPM (OR, 1.74; 95% CI, 1.39-2.18). Several values were significantly associated (P < .01) with strong consideration of CPM among women who said that the values were quite/very important at the time of treatment decision making: avoiding worry about the cancer coming back, avoiding exposure to radiation, requiring fewer trips back and forth for treatment, and choosing the treatments that were most extensive. Conversely, women who said it was quite/very important to choose treatments that were least extensive, allowed them to keep their natural breast, and were the same as those other women had undergone were significantly (P < .001) less likely to strongly consider CPM. Figure 2 displays a forest plot showing the multivariate parsimonious logistic regression results for strong consideration of CPM with adjustments for clustering at the surgeon level. Patients who had a family history of breast cancer and a larger breast cup size had higher odds of strong consideration of CPM than their counterparts (OR with a family history of breast cancer, 2.19; 95% CI, 1.65-2.91; OR with a larger breast cup size, 1.76; 95% CI, 1.17-2.65), whereas those from Georgia had lower odds (OR, 0.60; 95% CI, 0.42-0.85). Latina women also reported strong consideration of CPM more often than white women (OR, 2.14; 95% CI, 1.37-3.34), whereas African American women reported strong consideration of CPM less often than white women (OR, 0.63; 95% CI, 0.43-0.93). Two decision styles remained significantly associated with strong consideration of CPM in the multivariate model: women who preferred to make their own treatment decisions more often strongly considered CPM (OR, 1.56; 95% CI, 1.21-2.01), whereas women who reported being more logical in their decision making less often strongly considered CPM than those who reported following their heart (OR, 0.50; 95% CI, 0.34-0.72). Three values remained significant: avoiding worry about the cancer coming back (OR, 2.26; 95% CI, 1.40-3.66) and avoiding radiation exposure (OR, 2.85; 95% CI, 2.19-3.68) were both associated with strong consideration, whereas allowing the natural breast to be kept was significantly and inversely associated with strong consideration of CPM (OR, 0.12; 95% CI, 0.08-0.17) 
DISCUSSION
In this large, diverse, population-based sample of newly diagnosed breast cancer patients with a favorable prognosis, we found considerable variation both in the manner in which patients reported approaching treatment decision making (decision styles) and in what women valued at the time of treatment decision making; although most strongly valued avoiding worry about the cancer coming back, other factors were also important to many women. We further found that nearly a quarter of women strongly or very strongly considered having their unaffected breasts removed as part of treatment for their breast cancer, and another 29% considered it moderately or weakly. Our study contributes to the literature about the rise in CPM by deconstructing the decision-making process. Before the receipt of CPM, all patients must move through a process of weighing the treatment options and consider how the procedure aligns with their values. Factors associated with consideration, particularly strong consideration, are potentially actionable targets for education and intervention. Importantly, our results suggest that values matter slightly more than underlying personality traits in determining who strongly considers this procedure, although some decision styles are relevant. Our measure of decisional apprehension, developed to assess the type of person who may be more likely to make a decision for extensive treatment to avoid regretting it later, was notably not significantly associated with strong consideration when other factors were included in our model. Similarly, although most of the rational-intuitive items were not associated with strong consideration, women who endorsed being more logical in their decision making less often strongly considered this procedure. This held even when we controlled for the educational status, and this further underscores the importance of this finding across all types of patients. This finding further suggests that having a better understanding of a woman's underlying approach-logical versus more emotional (ie, "going with the gut")-may provide opportunities for individualizing the approach to education about risks and benefits.
We also found that women who reported desiring to play a more active role in decision making more often strongly considered CPM. This finding is consistent with prior work showing that more involved patients, those who reported making patient-driven decisions rather than shared or surgeon-driven decisions, more often chose mastectomy at a time when CPM was not a widely performed procedure.
10,11 Our current results confirm that such patient-led decision making is also associated with the consideration of even more extensive surgery than unilateral mastectomy. These findings call into question the notion that simply involving patients in decision making is likely to translate into less overtreatment. 20 They further suggest that perhaps we need to refocus efforts on targeting patients who desire considerable control in the decision-making process and on aspects of decision making that are not purely rational. The importance of affect in general decision making has been identified 21, 22 and highlighted in the seminal work by Kahneman. 23 Our findings support the idea that educational efforts in breast cancer treatment should address the intuitive or affective reactions that patients have to the meaning of the diagnosis and the prospects of the arduous treatment course as well as the cognitive aspects of decision making. For instance, it is not uncommon for patients to have activated intuitive/affective pathways of decision making rather than rational ones (a common psychological shortcut or heuristic). 23, 24 This may require interventions using methods targeted to this end, such as providing patient stories as well as numerical information to appeal to the emotional nature of this decision.
Several of the values measured in our study were associated with strong consideration in the anticipated direction when adjustments were made for patient and disease characteristics. When women valued things that would align with receiving more treatment, such as avoiding worry about recurrence and choosing treatments that were more extensive, they more often strongly considered CPM. Conversely, we also found that when women valued things that would align with less surgery, such as keeping their natural breast or choosing treatments that were less extensive, they less often strongly considered CPM.
The importance of these values, which have been identified in prior studies, reinforces the need to address directly patients' perceptions of the risk of recurrence and their reactions to it 25 because many patients overestimate the actual risk of recurrence after treatment. Furthermore, prior work by our team has shown an association between worry about recurrence and subsequent receipt of CPM. 4 This is particularly concerning because CPM does not confer a benefit for reducing recurrence risk or for longterm survival in the population studied in this analysis (non-BRAC1/2-positive and no strong family history of breast or ovarian cancer). [26] [27] [28] Our current finding, that worry is associated with consideration as well as utilization, suggests that interventions at the time when women are considering their treatment options may be useful. Furthermore, the powerful desire for many patients to avoid radiation motivates the need to ensure that they are well educated about the benefits and risks of treatment options that include this modality as an adjuvant.
Aspects of this study merit comment. The strengths of this study include a large, diverse sample, a high participation rate, and the use of unique patient-reported measures. However, the study has some limitations. Patients lived in 2 geographic regions, so they may not represent all US breast cancer patients. We did not have details on some practice factors that might have influenced patients' desire for CPM, such as information about breast reconstruction options and their availability. However, we did control for clustering by surgeon and geographic location. Finally, associations observed in the study are not necessarily causal.
Implications
Our results have important implications for patientclinician communication supporting individualized treatment decision making. Many more patients consider CPM, even in the absence of the potential for a survival benefit, in comparison with those who actually undergo the procedure. Assessing the decision styles and values of patients at or before the initial treatment encounter could provide an opportunity for improving deliberation by tailoring discussions about treatment options to embrace the patient's own style and values. There is a need to better educate patients about misperceptions associated with their values; for instance, it should be ensured that they understand the actual risk of recurrence because that value is associated with the consideration of more extensive treatment. Our results suggest that these are key areas for intervention, even in the context of quality improvement or other initiatives to ensure the appropriate use of treatments. These assessments can further help physicians to tailor communications to better target patients who may not wish to defer to physicians and/or those who are engaged in more intuitive decision processes than rational ones.
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